InvestorsHub Logo
Followers 6
Posts 355
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Friday, 07/06/2018 7:04:49 AM

Friday, July 06, 2018 7:04:49 AM

Post# of 403460
$5.5 BILLION market access for ELTP in less than a year!

APPROVALS for generic version of Norco and generic version of a synthetic narcotic analgesic should come at any time now! Elite is still working on the response to FDA for Oxycodone Hydrochloride ER so it's approval could come last of this year or early 2019. The approvals for the SUNGEN partnership products should be one in December 2018 and the other in March 2019. So by March 2019 ELITE Pharma could have approved drugs with market numbers of over $$ 5.5 BILLION $$ so with even a 1% market penetration ELITE Pharma could have revenue of over $55,000,000 and that does not even include the potential for SequestOX approval!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News